CIK: 0001844645 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 13, 2025
Total Value ($000): $148,066 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PCVX | VAXCYTE INC | 703,834 | $57,616 | 38.9% | $44.02 | +125.6% | COM | 92243G108 |
| OCS | OCULIS HOLDING AG | 1,737,696 | $29,541 | 20.0% | $10.09 | +56.0% | ORDINARY SHARES | H5870P102 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 2,120,508 | $29,539 | 19.9% | $11.27 | -2.7% | COM | 03969K108 |
| — | INOZYME PHARMA INC | 4,494,851 | $12,451 | 8.4% | $10.48 | — | COM | 45790W108 |
| ZBIO | ZENAS BIOPHARMA INC | 736,645 | $6,033 | 4.1% | $17.70 | -11.9% | COM | 98937L105 |
| RXRX | RECURSION PHARMACEUTICALS IN | 595,518 | $4,026 | 2.7% | $6.72 | 0.0% | CL A | 75629V104 |
| BIOA | BIOAGE LABS INC | 653,374 | $3,783 | 2.6% | $19.50 | -11.6% | COM | 09077V100 |
| — | RALLYBIO CORP | 2,404,644 | $2,308 | 1.6% | $16.97 | — | COM | 75120L100 |
| — | BOLT BIOTHERAPEUTICS INC | 1,891,467 | $1,021 | 0.7% | $32.91 | — | COM | 097702104 |
| — | VIGIL NEUROSCIENCE INC | 560,595 | $953 | 0.6% | $7.03 | — | COM | 92673K108 |
| IOBT | IO BIOTECH INC | 864,197 | $795 | 0.5% | $1.76 | -43.4% | COM | 449778109 |